Alert: Rating Upgrade (12/15/23)-Sarepta Therapeutics Inc (NASDAQ: SRPT).
Stock Rating Upgrade The Value Trend Rating for Sarepta Therapeutics Inc (NASDAQ: SRPT) rose significantly in recent days from F to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are […]